Close Menu

Top of the List

Francis Collins, the director of the US National Institutes of Health, told Congress this week that assessing the safety and efficacy of vaccines for COVID-19 is the agency's "top priority," according to CNBC. It adds that he further assured lawmakers that no steps would be omitted in that process.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.